Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
Status:
Completed
Trial end date:
2010-02-23
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, Phase 2 trial to study the effectiveness and feasibility of
association of trastuzumab with combination chemotherapy in advanced or metastatic bladder
cancer patients. Combining monoclonal antibody therapy with combination chemotherapy may
improve treatment efficacy on tumours overexpressed HER 2.